Us Pharmaceuticals
- All
- News
- Videos
-
How Trump's Policy For Prescription Drugs Could Reshape Trade With India
US President Donald Trump's announcement of sweeping prescription drug price cuts under a "Most Favoured Nation" policy has put India's pharmaceutical industry in focus.
-
Who Is Rama Raju Mantena? The Indian-American Pharma Titan Behind Viral Udaipur Wedding
Rama Raju Mantena is a prominent figure in the US pharmaceutical industry, serving as the Chairman and CEO of Ingenus Pharmaceuticals, a company with operations in the US, Switzerland, and India.
-
On Camera, Trump's Drug Event Paused As Man Faints At White House
President Donald Trump had a jump scare at the White House when a man collapsed while standing just behind him during an event in the Oval Office.
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
Gita Gopinath Slams Trump's Tariffs: "Negative Scorecard" For US Economy
Gita Gopinath evaluated the impact of US President Donald Trump's tariffs and concluded that they have yielded little to no benefits for the US economy.
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
EU Cites Trade Deal Immunity As Trump Hits Pharma With 100% Tariff
US President Donald Trump's announcement of steep new tariffs on medicines and other goods drew pushback from some allies on Friday, with the EU claiming immunity for its pharmaceutical industry under an earlier trade deal.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
"No 100% Tariff On Pharma Import To US If...": What Donald Trump Said
Donald Trump on Thursday announced 100 per cent tariffs on pharmaceutical drugs, saying they will take effect on October 1.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Trump Announces New Tariffs: 100% On Drugs, 50% On Kitchen Cabinets, Others
President Donald Trump said Thursday that he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on heavy trucks starting on Oct. 1.
-
Trump's 50% Tariffs Unlikely To Significantly Impact India's Growth: Analysts
As the deadline for US secondary tariffs of 25 per cent falls this week over Russian oil purchase, analysts say that a total of 50 per cent tariff is unlikely to significantly impact India's growth due to a robust domestic demand.
-
Why Trump's 50% Tariffs May Not Hurt India's Growth, S&P Rating Explains
US President Donald Trump's punitive tariffs on Indian imports will not impact India's economic growth, and its sovereign ratings outlook will remain positive, according to S&P Global Ratings Director YeeFarn Phua.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
How Trump's Policy For Prescription Drugs Could Reshape Trade With India
US President Donald Trump's announcement of sweeping prescription drug price cuts under a "Most Favoured Nation" policy has put India's pharmaceutical industry in focus.
-
Who Is Rama Raju Mantena? The Indian-American Pharma Titan Behind Viral Udaipur Wedding
Rama Raju Mantena is a prominent figure in the US pharmaceutical industry, serving as the Chairman and CEO of Ingenus Pharmaceuticals, a company with operations in the US, Switzerland, and India.
-
On Camera, Trump's Drug Event Paused As Man Faints At White House
President Donald Trump had a jump scare at the White House when a man collapsed while standing just behind him during an event in the Oval Office.
-
Trump May Exclude Generic Drugs From Tariffs. Good News For India?
The Donald Trump administration has dropped plans to impose tariffs on generic drugs from foreign countries, following months of debate over whether to impose taxes on the majority of medications prescribed in the US.
-
Gita Gopinath Slams Trump's Tariffs: "Negative Scorecard" For US Economy
Gita Gopinath evaluated the impact of US President Donald Trump's tariffs and concluded that they have yielded little to no benefits for the US economy.
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
EU Cites Trade Deal Immunity As Trump Hits Pharma With 100% Tariff
US President Donald Trump's announcement of steep new tariffs on medicines and other goods drew pushback from some allies on Friday, with the EU claiming immunity for its pharmaceutical industry under an earlier trade deal.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
"No 100% Tariff On Pharma Import To US If...": What Donald Trump Said
Donald Trump on Thursday announced 100 per cent tariffs on pharmaceutical drugs, saying they will take effect on October 1.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Trump Announces New Tariffs: 100% On Drugs, 50% On Kitchen Cabinets, Others
President Donald Trump said Thursday that he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on heavy trucks starting on Oct. 1.
-
Trump's 50% Tariffs Unlikely To Significantly Impact India's Growth: Analysts
As the deadline for US secondary tariffs of 25 per cent falls this week over Russian oil purchase, analysts say that a total of 50 per cent tariff is unlikely to significantly impact India's growth due to a robust domestic demand.
-
Why Trump's 50% Tariffs May Not Hurt India's Growth, S&P Rating Explains
US President Donald Trump's punitive tariffs on Indian imports will not impact India's economic growth, and its sovereign ratings outlook will remain positive, according to S&P Global Ratings Director YeeFarn Phua.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
